Travere gets patent allowance for Filspari use in kidney disease
Go back to Travere gets patent allowance for Filspari use in kidney disease| (NASDAQ: TVTX) | Delayed: 52.58 +0.28 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.30 | 52 Week High | $ | |||
| Open | $52.88 | 52 Week Low | $ | |||
| Day High | $54.83 | P/E | N/A | |||
| Day Low | $52.50 | EPS | $ | |||
| Volume | 2,164,174 | |||||



